Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck
- Status
- WITHDRAWN
- Phase
- PHASE2
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain Metastases
- Status
- TERMINATED
- Phase
- PHASE2
Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Pembrolizumab Plus Epacadostat With Platinum-based Chemotherapy Versus Pembrolizumab Plus Platinum-based Chemotherapy Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-715-06/ECHO-306-06)
- Status
- COMPLETED
- Phase
- PHASE2
Pembrolizumab Plus Epacadostat vs Pembrolizumab Plus Placebo in Metastatic Non-Small Cell Lung Cancer (KEYNOTE-654-05/ECHO-305-05)
- Status
- COMPLETED
- Phase
- PHASE2
Adjuvant Pembrolizumab for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma at High Risk of Recurrence
- Status
- COMPLETED
- Phase
- PHASE2
A Phase II a Study of Lenvatinib, a Multi-targeted Tyrosine Kinase Inhibitor, Combined With Pembrolizumab (PD-1 Inhibitor) for the Treatment of Metastatic Gastroesophageal Cancer Patients Who Have Progressed on First or Subsequent Line Therapies
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating Safety, Tolerability and Pharmacokinetics (PK) of Tarlatamab in Adults With Small Cell Lung Cancer (SCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy
- Status
- COMPLETED
- Phase
- PHASE2
Study of Pembrolizumab and Radiotherapy in Liver Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pembrolizumab in Neoplasms or Lymphomas
- Status
- SUSPENDED
- Phase
- PHASE2
Safety, Tolerability, and Immunogenicity of mRNA-4157 Alone and in Combination in Participants With Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
T-Cell PET Imaging With [18F]F-AraG in Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Expanded Access for Pembrolizumab (MK-3475)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of DSP-7888 Dosing Emulsion in Combination With Immune Checkpoint Inhibitors in Adult Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety and Efficacy of SGN-LIV1A Plus Pembrolizumab for Patients With Locally-Advanced or Metastatic Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Mogamulizumab and Pembrolizumab in Treating Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effects of Single Agent Niraparib and Niraparib Plus Programmed Cell Death-1 (PD-1) Inhibitors in Non-Small Cell Lung Cancer Participants
- Status
- COMPLETED
- Phase
- PHASE2
Sequencing of Stereotactic Ablative Body Radiotherapy in Combination With PD-1 Blockade Using Pembrolizumab in Metastatic Non-Small Cell Lung Carcinoma
- Status
- TERMINATED
- Phase
- PHASE1